Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Zurina Hassan, Muzaimi Mustapha, Visweswaran Navaratnam, et al.
Neuroscience & Biobehavioral Reviews (2012) Vol. 37, Iss. 2, pp. 138-151
Closed Access | Times Cited: 342

Showing 1-25 of 342 citing articles:

Patterns of Kratom use and health impact in the US—Results from an online survey
Oliver Grundmann
Drug and Alcohol Dependence (2017) Vol. 176, pp. 63-70
Closed Access | Times Cited: 257
Alkaloids Used as Medicines: Structural Phytochemistry Meets Biodiversity—An Update and Forward Look
Michael Heinrich, Jeffrey Mah, Vafa Amirkia
Molecules (2021) Vol. 26, Iss. 7, pp. 1836-1836
Open Access | Times Cited: 230
Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users
Darshan Singh, Christian P. Müller, Balasingam Vicknasingam
Drug and Alcohol Dependence (2014) Vol. 139, pp. 132-137
Closed Access | Times Cited: 224
Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 194
The pharmacology and toxicology of kratom: from traditional herb to drug of abuse
Marcus L. Warner, Nellie C. Kaufman, Oliver Grundmann
International Journal of Legal Medicine (2015) Vol. 130, Iss. 1, pp. 127-138
Closed Access | Times Cited: 192
Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam
Brain Research Bulletin (2016) Vol. 126, pp. 41-46
Closed Access | Times Cited: 187
The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel, Oliver Grundmann
Neuropharmacology (2017) Vol. 134, pp. 108-120
Closed Access | Times Cited: 187
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic
Albert Garcia‐Romeu, David J. Cox, Kirsten E. Smith, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107849-107849
Open Access | Times Cited: 144
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138
Kratom use and mental health: A systematic review
Marc T. Swogger, Zach Walsh
Drug and Alcohol Dependence (2017) Vol. 183, pp. 134-140
Closed Access | Times Cited: 133
Experiences of Kratom Users: A Qualitative Analysis
Marc T. Swogger, Elaine Hart, Fire Erowid, et al.
Journal of Psychoactive Drugs (2015) Vol. 47, Iss. 5, pp. 360-367
Closed Access | Times Cited: 130
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7‐hydroxymitragynine
Scott E. Hemby, Scot McIntosh, Francisco León, et al.
Addiction Biology (2018) Vol. 24, Iss. 5, pp. 874-885
Closed Access | Times Cited: 128
Abuse potential and adverse cognitive effects of mitragynine (kratom)
Nurul H.M. Yusoff, Farah Wahida Suhaimi, Raja Vadivelu, et al.
Addiction Biology (2014) Vol. 21, Iss. 1, pp. 98-110
Closed Access | Times Cited: 127
Pharmacokinetics of mitragynine in man
Winai Wananukul, Satariya Trakulsrichai, Korbtham Sathirakul, et al.
Drug Design Development and Therapy (2015), pp. 2421-2421
Open Access | Times Cited: 127
<p>Current perspectives on the impact of Kratom use</p>
Charles A. Veltri, Oliver Grundmann
Substance Abuse and Rehabilitation (2019) Vol. Volume 10, pp. 23-31
Open Access | Times Cited: 127
The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research
Jack E. Henningfield, Reginald V. Fant, Daniel W. Wang
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 573-589
Open Access | Times Cited: 123
Kratom as a substitute for opioids: Results from an online survey
Marion A. Coe, Janine L. Pillitteri, Mark A. Sembower, et al.
Drug and Alcohol Dependence (2019) Vol. 202, pp. 24-32
Closed Access | Times Cited: 123
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
Kirsten E. Smith, Thomas Lawson
Drug and Alcohol Dependence (2017) Vol. 180, pp. 340-348
Closed Access | Times Cited: 116
Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine
Alicia G. Lydecker, Abhisheak Sharma, Christopher R. McCurdy, et al.
Journal of Medical Toxicology (2016) Vol. 12, Iss. 4, pp. 341-349
Open Access | Times Cited: 113
A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom
Paula N. Brown, Jensen A. Lund, Susan J. Murch
Journal of Ethnopharmacology (2017) Vol. 202, pp. 302-325
Closed Access | Times Cited: 107
Biased Opioid Ligands
Abdelfattah Faouzi, Balázs Varga, Susruta Majumdar
Molecules (2020) Vol. 25, Iss. 18, pp. 4257-4257
Open Access | Times Cited: 105
Neurobiology of Kratom and its main alkaloid mitragynine
Farah Wahida Suhaimi, Nurul H.M. Yusoff, Rahimah Hassan, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 29-40
Closed Access | Times Cited: 95
Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat
Flaminia Pantano, Roberta Tittarelli, Giulio Mannocchi, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 4, pp. 580-580
Open Access | Times Cited: 94
Discovering Alternative Treatments for Opioid Use Recovery Using Social Media
Stevie Chancellor, George C. Nitzburg, Andrea Hu, et al.
(2019), pp. 1-15
Closed Access | Times Cited: 91
Page 1 - Next Page

Scroll to top